GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NuCana PLC (NAS:NCNA) » Definitions » Pre-Tax Income

NuCana (NuCana) Pre-Tax Income : $-39.83 Mil (TTM As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is NuCana Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. NuCana's pretax income for the three months ended in Dec. 2023 was $-11.35 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was $-39.83 Mil. NuCana's pretax margin was %.


NuCana Pre-Tax Income Historical Data

The historical data trend for NuCana's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NuCana Pre-Tax Income Chart

NuCana Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only -33.62 -48.62 -63.57 -46.84 -40.54

NuCana Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -20.66 -10.75 -7.70 -10.03 -11.35

Competitive Comparison of NuCana's Pre-Tax Income

For the Biotechnology subindustry, NuCana's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NuCana's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NuCana's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where NuCana's Pre-Tax Income falls into.



NuCana Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

NuCana's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-39.399+-2.1+0+0.954+0.0010000000000048
=-40.54

NuCana's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-10.31+-1.218+0+0.173+0.0010000000000012
=-11.35

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-39.83 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NuCana  (NAS:NCNA) Pre-Tax Income Explanation

NuCana's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin=Pretax Income/Revenue
=-11.354/0
=%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NuCana Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of NuCana's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


NuCana (NuCana) Business Description

Traded in Other Exchanges
Address
3 Lochside Way, Edinburgh, GBR, EH12 9DT
NuCana PLC is a biopharmaceutical company focused on improving treatment outcome for cancer patients by ProTide technology. Utilising proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. Geographically operates through the region of the United States.

NuCana (NuCana) Headlines

From GuruFocus

NuCana Regains Compliance with Nasdaq Minimum Bid Price Requirement

By Stock market mentor Stock market mentor 01-23-2023

NuCana to Participate in Two Upcoming Investor Conferences

By sperokesalga sperokesalga 02-28-2023

NuCana to Present at the Jefferies Healthcare Conference

By sperokesalga sperokesalga 06-01-2023

NuCana Announces Receipt of NASDAQ Notice

By Stock market mentor Stock market mentor 01-06-2023

NuCana Announces Receipt of Nasdaq Notice

By sperokesalga sperokesalga 05-12-2023